Log In
Print this Print this

Ondemet, ondansetron

  Manage Alerts
Collapse Summary General Information
Company Beacon Pharmaceuticals Ltd.
DescriptionA competitive serotonin type 3 receptor agonist
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEmesis
Indication DetailsTreat chemotherapy induced nausea and vomiting (CINV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today